DocMorris AG (ZRSEF)
USD 21.6
(-40.36%)
USD 21.6
(-40.36%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 969.46 Million CHF | -39.88% |
| 2022 | 1.6 Billion CHF | -6.85% |
| 2021 | 1.72 Billion CHF | 16.9% |
| 2020 | 1.47 Billion CHF | 8.96% |
| 2019 | 1.35 Billion CHF | 12.3% |
| 2018 | 1.2 Billion CHF | 22.81% |
| 2017 | 982.92 Million CHF | 11.75% |
| 2016 | 879.53 Million CHF | 5.41% |
| 2015 | 834.41 Million CHF | -8.86% |
| 2014 | 915.55 Million CHF | 0.54% |
| 2013 | 910.6 Million CHF | 74.01% |
| 2012 | 523.3 Million CHF | 7.41% |
| 2011 | 487.19 Million CHF | -0.22% |
| 2010 | 488.26 Million CHF | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 248.14 Million CHF | 0.0% |
| 2024 Q1 | 248.14 Million CHF | -51.01% |
| 2023 Q3 | 253.25 Million CHF | -45.3% |
| 2023 Q2 | 462.95 Million CHF | 100.0% |
| 2023 FY | 966.9 Million CHF | -39.88% |
| 2023 Q1 | 231.47 Million CHF | -70.48% |
| 2023 Q4 | 506.5 Million CHF | 100.0% |
| 2022 Q3 | 218.16 Million CHF | -73.52% |
| 2022 FY | 1.6 Billion CHF | -6.85% |
| 2022 Q1 | 247.32 Million CHF | -72.11% |
| 2022 Q2 | 823.96 Million CHF | 233.15% |
| 2022 Q4 | 784.25 Million CHF | 259.48% |
| 2021 Q2 | 839.78 Million CHF | 100.0% |
| 2021 FY | 1.72 Billion CHF | 16.9% |
| 2021 Q1 | 419.89 Million CHF | -46.09% |
| 2021 Q4 | 886.71 Million CHF | 100.0% |
| 2021 Q3 | 443.35 Million CHF | -47.21% |
| 2020 Q3 | 389.46 Million CHF | -44.2% |
| 2020 FY | 1.47 Billion CHF | 8.96% |
| 2020 Q4 | 778.93 Million CHF | 100.0% |
| 2020 Q2 | 697.99 Million CHF | 100.0% |
| 2020 Q1 | 348.99 Million CHF | -49.21% |
| 2019 FY | 1.35 Billion CHF | 12.3% |
| 2019 Q1 | 334.18 Million CHF | 10.73% |
| 2019 Q2 | 668.36 Million CHF | 100.0% |
| 2019 Q4 | 687.17 Million CHF | 100.0% |
| 2019 Q3 | 343.58 Million CHF | -48.59% |
| 2018 Q2 | 301.74 Million CHF | 0.0% |
| 2018 FY | 1.2 Billion CHF | 22.81% |
| 2018 Q1 | 301.74 Million CHF | 15.66% |
| 2018 Q4 | 301.8 Million CHF | 0.0% |
| 2018 Q3 | 301.8 Million CHF | 0.02% |
| 2017 Q2 | 237.6 Million CHF | 2.84% |
| 2017 Q1 | 231.05 Million CHF | 3.43% |
| 2017 FY | 982.92 Million CHF | 11.75% |
| 2017 Q4 | 260.89 Million CHF | 0.0% |
| 2017 Q3 | 260.89 Million CHF | 9.8% |
| 2016 Q4 | 223.38 Million CHF | 0.0% |
| 2016 Q3 | 223.38 Million CHF | 0.79% |
| 2016 Q2 | 221.62 Million CHF | 2.88% |
| 2016 Q1 | 215.43 Million CHF | 1.53% |
| 2016 FY | 879.53 Million CHF | 5.41% |
| 2015 Q1 | 207.04 Million CHF | -10.1% |
| 2015 Q4 | 212.17 Million CHF | 0.0% |
| 2015 Q3 | 212.17 Million CHF | 2.48% |
| 2015 FY | 834.41 Million CHF | -8.86% |
| 2015 Q2 | 207.04 Million CHF | 0.0% |
| 2014 Q2 | 229.89 Million CHF | 0.0% |
| 2014 Q1 | 229.89 Million CHF | 0.36% |
| 2014 Q4 | 230.29 Million CHF | 0.0% |
| 2014 FY | 915.55 Million CHF | 0.54% |
| 2014 Q3 | 230.29 Million CHF | 0.17% |
| 2013 Q2 | 228.73 Million CHF | 0.0% |
| 2013 Q3 | 229.06 Million CHF | 0.14% |
| 2013 Q4 | 229.06 Million CHF | 0.0% |
| 2013 FY | 910.6 Million CHF | 74.01% |
| 2013 Q1 | 228.73 Million CHF | 0.0% |
| 2012 FY | 523.3 Million CHF | 7.41% |
| 2011 FY | 487.19 Million CHF | -0.22% |
| 2010 FY | 488.26 Million CHF | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -396.552% |
| Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -2175777.006% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 20.28 Million USD | -4679.598% |
| LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -638.278% |
| MedGen, Inc. | 1.05 USD | -92329714185.714% |
| Omni Health, Inc. | 4.69 Million USD | -20547.534% |
| Oxford Investments Holdings Inc. | 61.16 Thousand USD | -1584842.861% |
| Pineapple, Inc. | 381.89 Thousand USD | -253758.965% |
| ScripsAmerica, Inc. | 30.85 Million USD | -3042.028% |